Supplemental Methods:
ParM wild-type and cysteine mutants used in the initial screen for a fluorescence signal (Table S1) were expressed without His 6 -tag. They were purified by ammonium sulfate precipitation followed by one cycle of polymerization/depolymerization as described (1), except that subsequent size-exclusion chromatography was performed on a 120 mL HiLoad Superdex 75 column (GE Healthcare) in 30 mM Tris⋅HCl pH 7.5, 25 mM KCl and 1 mM EDTA. This procedure completely removed DTT and nucleotide present from the preceding polymerization step. Proteins were concentrated and ParM concentrations were determined from the absorbance at 280 nm as described in Experimental Procedures.
In order to screen for a fluorescence change upon ADP binding (Table S1 ) and to test different active site mutations for ADP selectivity (Table S2) , labeling was performed on a scale of 2-3 mg protein. ParM mutants (100-150 µM) and 2-fold (maleimides) or 4-fold (iodoacetamides) excess of fluorophore over ParM were incubated in 30 mM Tris⋅HCl pH 7.5, 25 mM KCl with endover-end mixing at 22 °C. After 45 min (maleimides) or 90 min (iodoacetamides), 2 mM sodium 2-mercaptoethanesulfonate was added and the solutions were incubated for another 15 min. Reaction mixtures were centrifuged (15000 g, 10 min, 4 °C) and the supernatant was filtered through a 0.2 µM Acrodisc filter (Pall Corporation). Free fluorophore was removed by two successive PD10 columns (GE Healthcare) using the same buffer as for labeling.
Competitive titrations
Binding of GDP to the MDCC-ParM biosensor does not result in a large fluorescence change; therefore GDP affinity was determined by competitive titrations. These were measured at 20 °C using a Cary Eclipse spectrofluorimeter (Varian). Titrations were carried out in 30 mM 
ATP hydrolysis of MDCC-ParM
The rate of ATP hydrolysis by MDCC-labeled ParM variants was measured using the phosphate biosensor Rhodamine-PBP (3). 10 µM Rhodamine-PBP and 10 µM MDCC-ParM in 30 mM Tris buffer pH 7.5, 25 mM KCl, 3 mM MgCl 2 were pre-incubated at 20 °C for 3 min before 500 µM ATP was added. The time course of the reaction was measured by recording the fluorescence change of Rhodamine-PBP using a Cary Eclipse spectrofluorimeter (Varian). The fluorescence was excited at 553 nm and emission was detected at 578 nm. As a control, the experiment was repeated in the absence of MDCC-ParM. The fluorescence signal was calibrated by titrating Rhodamine-PBP with a phosphate standard solution. To determine the ATP hydrolysis rate of MDCC-ParM data were corrected by subtracting the control experiment in the absence of ParM.
Light scattering measurements
Polymerization kinetics of different ParM variants were measured by monitoring right angle light scattering at 340 nm in a Cary Eclipse spectrofluorimeter (Varian). ParM solutions were centrifuged in a TLA120.1 rotor (Beckman) at 100,000 rpm for 15 min prior to the scattering experiments. Solutions of ParM variants in 30 mM Tris⋅HCl pH 7.5, 25 mM KCl, 3 mM MgCl 2 were incubated in the cuvette at 20 °C for 5 min, before ATP, ADP or only buffer were added. Scattering intensities were corrected by subtracting the intensity measured before addition of nucleotide. To determine the critical concentration in presence of ATP, the maximal scattering intensities were plotted versus ParM concentration. Critical concentrations were obtained by linear extrapolation to zero scattering intensity.
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Alexandrov, K., Scheidig, A. J., and Goody, R. S. (2001) The fluorescence change is expressed as ratio of the intensity in presence of 1 mM ADP to that in the absence of ADP. Where no number is shown, the combination of fluorophore and mutant was not tested. C287 of the wild-type ParM is located in the vicinity of the nucleotide binding site, fluorescent probes attached to this position might report ADP binding. Therefore, the wild-type protein was labeled with a series of different fluorophores but all showed a decrease in fluorescence intensity on addition of ADP. Other mutations were introduced in the C287A variant. Data were obtained from fluorescence titrations at 20 °C in 30 mM Tris⋅HCl buffer pH 7.5, 25 mM KCl, 3 mM MgCl 2 and 5 µM BSA. ATP titrations were performed with highly purified ATP. "I27C/C287A only" denotes MDCC-ParM (I27C/C287A). All other mutants are based on MDCC-ParM (His 6 /I27C/C287A), including a C-terminal His 6 -tag together with the additional mutations shown in the table. 
